The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer

Citation
Dk. Price et al., The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancer, CANCER INV, 18(8), 2000, pp. 722-730
Citations number
24
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER INVESTIGATION
ISSN journal
07357907 → ACNP
Volume
18
Issue
8
Year of publication
2000
Pages
722 - 730
Database
ISI
SICI code
0735-7907(2000)18:8<722:TPOIDE>2.0.ZU;2-C
Abstract
To identify potential prognostic indicators of ovarian cancer and identify targets for therapeutic strategies, mRNA differential display was used to a nalyze gene expression differences in normal, benign, and cancerous ovarian tissue. One cDNA isolated by this technique, Op18/stathmin, is a highly co nserved gene that is reported to have many different functions within a cel l, including signal transduction, control of the cell cycle, and the regula tion of microtubules. Quantitative Northern blot analysis of 12 malignant o varian samples, 8 benign ovarian tumors, and 10 normal ovarian tissue sampl es demonstrated overexpression of Op18/stathmin mRNA in the malignant cance rs. Immunohistochemistry showed an apparent overexpression of Op18/stathmin protein level and an association with proliferating cells.